공시 • 23h
Skin Elements Limited has filed a Follow-on Equity Offering in the amount of AUD 0.9 million. Skin Elements Limited has filed a Follow-on Equity Offering in the amount of AUD 0.9 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 300,000,000
Price\Range: AUD 0.003
Transaction Features: Subsequent Direct Listing 공시 • Jun 24
Skin Elements Limited Announces Board Resignations, Effective June 22, 2026 Skin Elements Limited advised that Brett Fraser, Stuart Usher and Robin Armstrong have resigned as directors with such changes effective 22 June 2026. 공시 • Jun 23
Skin Elements Limited Approves the Election of Board of Directors Skin Elements Limited announced the results of the Extraordinary General Meeting held on June 23, 2026. The Company approved the appointment of Mr. Frank Knezovic, Mr. Gorakanage Ishan Malinda Peries, and Mr. Harry Michael Spindler as directors. 공시 • Jun 02
Skin Elements Limited Approves Removal of Dr Peter Francis Malone as A Director Skin Elements Limited announced that at its EGM held on June 2, 2026, approved that DR PETER FRANCIS MALONE removed as a director. Board Change • May 20
No independent directors There are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 5 new directors. No experienced directors. 1 highly experienced director. No independent directors (6 non-independent directors). Executive Chairman, CEO & MD Peter Malone is the most experienced director on the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors. 공시 • May 14
Skin Elements Limited Receive Further Notice from Kingsbury Wealth Pty Ltd On May 14, 2026, Skin Elements Limited announced that it has received a further request to call a meeting of the shareholders of the Company from Kingsbury Wealth Pty Ltd to consider resolutions to remove directors from the board of the Company that an Extraordinary General Meeting of shareholders of the will be held on June 23, 2026. The Company stated that the Company’s other Directors, Peter Francis Malone and Messrs Filippo (Phil) Leone Giglia, Roderick Anthony Nicholas and Joshua Gordon, are not the subject of removal Resolutions at the Meeting. Additionally, the board recommends that shareholders vote against each of the resolutions. Board Change • May 01
No independent directors There are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 5 new directors. No experienced directors. 1 highly experienced director. No independent directors (6 non-independent directors). Executive Chairman, CEO & MD Peter Malone is the most experienced director on the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors. 공시 • Oct 31
Skin Elements Limited, Annual General Meeting, Nov 28, 2025 Skin Elements Limited, Annual General Meeting, Nov 28, 2025. Location: level 1, westcentre , 1260 hay street, west perth, wa 6005 Australia 공시 • Oct 15
Skin Elements Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million. Skin Elements Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 157,500,000
Price\Range: AUD 0.002
Discount Per Security: AUD 0.00012
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 1,092,500,000
Price\Range: AUD 0.002
Discount Per Security: AUD 0.00012
Transaction Features: Subsequent Direct Listing 공시 • Mar 13
Skin Elements Limited has completed a Follow-on Equity Offering in the amount of AUD 0.643692 million. Skin Elements Limited has completed a Follow-on Equity Offering in the amount of AUD 0.643692 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 136,894,740
Price\Range: AUD 0.003
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 34,335,812
Price\Range: AUD 0.003
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 43,333,333
Price\Range: AUD 0.003
Transaction Features: Rights Offering 공시 • Dec 21
Skin Elements Limited has filed a Follow-on Equity Offering in the amount of AUD 0.513692 million. Skin Elements Limited has filed a Follow-on Equity Offering in the amount of AUD 0.513692 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 136,894,740
Price\Range: AUD 0.003
Security Features: Attached Options
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 34,335,812
Price\Range: AUD 0.003
Transaction Features: Rights Offering 공시 • Oct 30
Skin Elements Limited, Annual General Meeting, Nov 29, 2024 Skin Elements Limited, Annual General Meeting, Nov 29, 2024. Location: at 1242 hay street, west perth wa 6005 Australia Reported Earnings • Oct 04
Full year 2024 earnings released: AU$0.004 loss per share (vs AU$0.026 loss in FY 2023) Full year 2024 results: AU$0.004 loss per share (improved from AU$0.026 loss in FY 2023). Revenue: AU$416.2k (up 114% from FY 2023). Net loss: AU$2.16m (loss narrowed 81% from FY 2023). Reported Earnings • Aug 31
Full year 2024 earnings released: AU$0.003 loss per share (vs AU$0.026 loss in FY 2023) Full year 2024 results: AU$0.003 loss per share (improved from AU$0.026 loss in FY 2023). Revenue: AU$416.2k (up 114% from FY 2023). Net loss: AU$1.87m (loss narrowed 84% from FY 2023). New Risk • Mar 02
New major risk - Negative shareholders equity The company has negative equity. Total equity: -AU$287k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$810k free cash flow). Negative equity (-AU$287k). Earnings have declined by 38% per year over the past 5 years. Revenue is less than US$1m (AU$183k revenue, or US$119k). Market cap is less than US$10m (AU$2.82m market cap, or US$1.84m). Minor Risk Shareholders have been diluted in the past year (28% increase in shares outstanding). Board Change • Oct 11
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Phil Giglia was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 05
Full year 2023 earnings released: AU$0.026 loss per share (vs AU$0.004 loss in FY 2022) Full year 2023 results: AU$0.026 loss per share (further deteriorated from AU$0.004 loss in FY 2022). Revenue: AU$194.1k (down 86% from FY 2022). Net loss: AU$11.4m (loss widened AU$9.84m from FY 2022). Reported Earnings • Sep 01
Full year 2023 earnings released: AU$0.009 loss per share (vs AU$0.004 loss in FY 2022) Full year 2023 results: AU$0.009 loss per share (further deteriorated from AU$0.004 loss in FY 2022). Net loss: AU$4.10m (loss widened 160% from FY 2022). New Risk • Aug 31
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.8m free cash flow). Shares are highly illiquid. Earnings have declined by 2.0% per year over the past 5 years. Revenue is less than US$1m (AU$1.4m revenue, or US$896k). Market cap is less than US$10m (AU$3.26m market cap, or US$2.11m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (33% increase in shares outstanding). Board Change • Aug 15
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Phil Giglia was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 공시 • May 26
Skin Elements Limited, Annual General Meeting, Jun 27, 2023 Skin Elements Limited, Annual General Meeting, Jun 27, 2023, at 10:30 W. Australia Standard Time. Location: 1242 Hay Street, West Perth West Perth Western Australia Australia Agenda: To consider remuneration report; to consider approval of 10% placement facility; to consider re-election of Filippo Giglia as a director; to consider election of Stuart Douglas usher as a director; to consider ratification of prior issue of optionslisting rule 7.1; to consider ratification of prior issue of optionslisting rule 7.1A; to consider proposed issue of shares and options to 708 capital pty ltd for underwriting fee; to consider proposed issue of options to 708 capital pty ltd for lead manager services; and to consider other issues. Board Change • May 02
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Phil Giglia was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Apr 04
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Phil Giglia was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Mar 08
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Phil Giglia was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Jan 24
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Phil Giglia was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 공시 • Jan 17
Skin Elements Limited Announces Executive Changes Skin Elements Limited announced that it has appointed Mr. Stuart Usher as a Non- Executive Director to the Board and as Company Secretary. Mr. Usher is a CPA and Chartered Company Secretary with over 25 years of extensive experience in the management and corporate affairs of public listed companies in Australian and Internationally, including as Company Director and Company Secretary for several other listed public companies. He holds an MBA from the University of Western Australia and has extensive experience across many industries focusing on Corporate & Financial Management, Strategy & Planning, Mergers & Acquisitions, and Investor Relations & Corporate Governance. Mr. Usher's experience is particularly applicable to Skin Elements as an emerging growth company, working with the Board and senior management team to support delivery of financial, operational, and strategic goals and market share as the Company transitions from research & development to commercial operations for its natural antimicrobial technology. Mr. Usher is also appointed as Company Secretary replacing Mr. Phil Giglia in this role. SKN also announced of the resignation of Mr. Lee Christensen as Non-Executive Director to focus on other projects. Board Change • Oct 07
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Kevin Christensen was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 02
Full year 2022 earnings released: AU$0.004 loss per share (vs AU$0.009 loss in FY 2021) Full year 2022 results: AU$0.004 loss per share (improved from AU$0.009 loss in FY 2021). Revenue: AU$1.41m (up 388% from FY 2021). Net loss: AU$1.58m (loss narrowed 48% from FY 2021). Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Reported Earnings • Sep 02
Full year 2022 earnings released Full year 2022 results: Revenue: AU$1.41m (up 388% from FY 2021). Net loss: AU$1.62m (loss narrowed 47% from FY 2021). Board Change • Aug 25
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Kevin Christensen was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Apr 28
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Kevin Christensen was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Oct 21
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Lee Christensen was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.